kevindalby

Originally published on  personal-development.com There is more to March besides dusting off that outfit of green for St. Patrick’s Day. March is also Colorectal Cancer Awareness Month. Spreading the awareness of colorectal cancer is essential, especially since its month of awareness is not widely known. Dr. Kevin Dalby , professor at The University of Texas at Austin, is one of the dedicated scientists working towards cancer drug discovery. Though the future of cancer treatments holds hope, Dalby expresses the importance of education and awareness of cancer types such as colorectal cancer and how taking the appropriate steps can save lives. What is Colorectal Cancer? Colorectal cancer is cancer found in the  colon or rectum . It is the third most common cancer found in both men and women in the United States, with more than  145,600 people  predicted to undergo diagnosis this year. Also, colorectal cancer lies in second place for cancer-caused deaths and will kill m

Dr. Kevin Dalby is a professor of chemical biology and medicinal chemistry in the College of Pharmacy, and Department of Oncology at The University of Texas in Austin. He is studying the mechanisms of cancer cell signaling to develop targeted therapeutics. The Cancer Prevention and Research Institute of Texas (CPRIT) and the National Institutes of Health, recognized Dr. Dalby's efforts by granting him nearly $5 million to support his research. Kevin Dalby has been interested in the “why” of chemical reactions since he was a student at the University of Cambridge, where he graduated with a Doctor of Philosophy degree in Organic Chemistry. This curiosity has led to his interest in the processes of cell signaling, and ultimately to cancer research. Dr. Dalby's research areas include biochemistry, cancer, cell biology, chemical biology, drug discovery & diagnostics, and enzymology. He is a director of The Targeted Therapeutic Drug Discovery & Development Program (TT